Acadian Asset Management
NUVB icon

Acadian Asset Management’s Nuvation Bio NUVB Stock Holding History

Acadian Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-653,184
Closed -$1.91M – 2267
2024
Q2 		$1.91M Sell
653,184
-521,280
-44% -$1.59M 0.01% 781
2024
Q1 		$4.27M Buy
1,174,464
+528,660
+82% +$1.02M 0.01% 509
2023
Q4 		$973K Buy
645,804
+532,087
+468% +$685K ﹤0.01% 862
2023
Q3 		$150K Buy
113,717
+82,031
+259% +$137K ﹤0.01% 1241
2023
Q2 		$57K Buy
+31,686
New +$53.9K ﹤0.01% 1508

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Acadian Asset Management's NUVB Position: Q3 2024 in Review

Acadian Asset Management sold out of Nuvation Bio (NUVB) in Q3 2024, closing a stake of 653,184 shares — an estimated $1.91M sold.

Acadian Asset Management first reported a position in NUVB in Q2 2023 and held it in 5 quarters. The position peaked at $4.27M in Q1 2024. 154 funds tracked by Wall St. Rank hold NUVB as of Q3 2024.

  • Acadian Asset Management reported no remaining Nuvation Bio position as of Q3 2024 after selling out during the quarter.
  • Acadian Asset Management sold 653,184 Nuvation Bio shares in Q3 2024, an estimated $1.91M.
  • Acadian Asset Management first reported a position in Nuvation Bio in Q2 2023 and held it in 5 quarters.
  • Acadian Asset Management's Nuvation Bio position peaked at $4.27M in Q1 2024.
  • 154 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2024.

Based on Acadian Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.